Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
AI-Assisted Triage and Decision Support of Head and Neck Cancer Screening and Diagnosis in Low-Resourced Settings
0
Zitationen
8
Autoren
2024
Jahr
Abstract
The mortality burden of head and neck cancer (HNC) is increasing globally and disproportionately affects people in low-and middle-income countries with limited medical workforce. To address this issue, artificial intelligence (AI) algorithms are increasingly being explored to process medical imaging data, demonstrating competitive performance. However, the clinical adoption of AI remains challenging as clinicians struggle to understand how complex AI works and trust it to use in practice. In addition, AI may not perform well on varying data qualities of endoscopy videos for HNC screening and diagnosis from multiple sites. In this project, our international and interdisciplinary team will collaborate with clinicians from multiple sites (e.g. Singapore, the U.S., and Bangladesh) to collect a diverse, multi-site dataset. In addition, we aim to design and develop computational techniques and practices to improve collaborations between clinicians and AI for the triage and diagnosis of HNC. Specifically, these techniques include a YOLOv5-based glottis detector, a classifier of patient's status using clinical endoscopy videos, uncertainty quantification techniques, and interactive Vision Language Model-based AI explanations, which will enable clinicians to understand AI outputs and provide their inputs to improve AI. After developing our system, we will evaluate the effectiveness of these computational techniques in enabling AI-assisted point-of-care triage and decision-support for HNC, particularly in resource-limited settings.
Ähnliche Arbeiten
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
1993 · 15.649 Zit.
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 · 6.411 Zit.
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 · 5.076 Zit.
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
2016 · 4.947 Zit.
Head and neck squamous cell carcinoma
2020 · 3.834 Zit.
Autoren
Institutionen
- Singapore Management University(SG)
- Human Services Research Institute(US)
- SingHealth(SG)
- Duke-NUS Medical School(SG)
- SingHealth Duke-NUS Academic Medical Centre(SG)
- National Cancer Centre Singapore(SG)
- Singapore General Hospital(SG)
- Cancer Institute (WIA)(IN)
- Duke University Health System(US)
- Duke Cancer Institute
- Duke Medical Center(US)